Global Director, Integrated Evidence Strategy - Global Medical Affairs
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Søborg
Are you an experienced leader passionate about change management and process transformation? Are you looking for a position in which you will set direction and change ways of evidence planning across the entire Novo Nordisk value chain? Then have a look at this exciting job opportunity. Apply now! About the department Global Medical Affairs (GMA) improves patients’ lives by being the leading partner in the generation, interpretation, and communication of scientific data with relevant stakeholders. We build the scientific foundation for the next generation of products across disease areas and sustain the strong scientific position of products marketed in over 165 countries. As part of focus areas, we drive key strategic process of cross-functional Integrated Evidence Strategy (IES) process within the Global organisation. The position
You will report to the CVP of Medical Portfolio within Global Medical Affairs. You will be responsible for heading up and setting direction for the Integrated Evidence Strategy function. Our ambition is to establish and strengthen the role of the IES function as a key value contribution and deliverable to the Novo Nordisk value chain. You will head up the GMA Integrated Evidence Strategy (IES) team and drive further integration and strengthening of this function into core processes within Development and our Commercial organisation. Your responsibilities will include: Providing vision and setting direction for the GMA IES team Being the driving force behind transforming the traditional evidence planning processes towards an integrated process, and strengthening the role and value contribution of GMA IES across the organisation Identifying and setting ambitious targets for the function to support projects within key therapy areas in collaboration with adjacent functions Driving initiatives to strengthen the evidence planning process across various levels of the organisation, e.g., Regions and Operations Driving IES digitalization efforts in collaboration with the Digital Transformation Office Identifying internal and external opportunities for continuous IES process- and project excellence Qualifications We encourage candidates with a variety of backgrounds to apply, but you are required to have a relevant high-level education, preferably in life-science or relevant field, and solid understanding of pharmaceutical value chain and cross-functional evidence planning processes supporting it. In additional the above, a successful candidate also needs to show: A track-record of transforming core processes across the enterprise Strong and well-documented leadership skills People management and communication capabilities Experience with engaging in a global cross-functional team Experience from evidence planning function within evidence planning, access or HEOR will be considered an advantage As a person, you are ambitious, flexible and your interpersonal skills are second to none, enabling you to build trusting relationships across organisational levels and drive the needed change management and secure business continuity. You have a track-record of developing people, both in your formal line of responsibility and through informal leadership. You are a strong presenter and motivator which allows you to create buy-in to your initiatives. This is combined with strong negotiation skills. As a leader you can prioritise efforts to maximise the impact of the team and in this environment, you are recognised as a strong collaborator and facilitator and can identify solutions to complex challenges that meet stakeholder expectations. Working at Novo Nordisk Novo Nordisk is its people. We know that life is anything but linear, and balancing what is important at different stages of our career is never easy. That’s why we make room for diverse life situations, always putting people first. We value our employees for the unique skills they bring to the table, and we work continuously to bring out the best in them. Working at Novo Nordisk is working toward something bigger than ourselves, and it’s a collective effort. Novo Nordisk relies on the joint potential and collaboration of its more than 50,000 employees. Together, we go further. Together, we’re life changing. Contact For further information, please contact CVP of Medical Portfolio, Shafik Tawadros on [email protected] Deadline Sunday 7th January 2024. The process for handling all incoming applications will happen on an on-going basis. You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV. To ensure a fair recruitment process, please refrain from adding a photo in your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
You will report to the CVP of Medical Portfolio within Global Medical Affairs. You will be responsible for heading up and setting direction for the Integrated Evidence Strategy function. Our ambition is to establish and strengthen the role of the IES function as a key value contribution and deliverable to the Novo Nordisk value chain. You will head up the GMA Integrated Evidence Strategy (IES) team and drive further integration and strengthening of this function into core processes within Development and our Commercial organisation. Your responsibilities will include:
Information og data
Denne ledige stilling har jobtypen "Øvrige", og befinder sig i kategorien "Øvrige stillinger".
Arbejdsstedet er beliggende i Søborg.
Jobbet er oprettet på vores service den 21.12.2023, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Øvrige
- Søborg
Lignende jobs
-
Øvrige i København Ø
Fri kontaktSenior Associates og Managere til Transaction Advisory Service i København. Vi mærker en stigende efterspørgsel efter rådgivning i forbindelse med køb og salg af virksomheder, herunder finansiel due diligence. Derfor søger vi Senior Associates og Managere til vores TAS team på Østerbro.Få mere info- Øvrige
- København Ø
-
Øvrige i København
Fri kontaktEr du ambitiøs, målrettet og ikke bange for at rydde vanetænkning af bordet, så tror vi på, at du er vores nye Food & Beverage Manager på Scandic Spectrum. Vi ved, at du ta’r ansvar og har ro i maven med det fulde overblik. Du er god til at organisere, købe ind, lede og dele din viden.Få mere info- Øvrige
- København
-
Øvrige (studiejob) i København
Fri kontaktBrænder du for regnskab og har en skarp analytisk sans? Så tror vi på, at du er vores nye studentermedhjælper på Scandics Support Office. Vi ved, at du er en haj til Office-pakken, herunder især Excel og at du trives med mange og forskelligartede opgaver.Få mere info- Øvrige
- København
-
Øvrige i København
Fri kontaktEr du ambitiøs og målrettet og god til at håndtere alverdens spørgsmål, så tror vi på, at du er vores nye Shiftleader på Scandic Spectrum. Vi ved, at du ta’r ansvar, har overblik og handler hurtigt, når det gælder.Få mere info- Øvrige
- København
Statistik over udbudte jobs som øvrige i Søborg
Herunder ser du udviklingen i udbudte øvrige i Søborg over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal øvrige.
Se flere statistikker her:
Statistik over udbudte øvrige i Søborg over tid
| Dato | Alle jobs som øvrige |
|---|---|
| 5. juli 2024 | 72 |
| 4. juli 2024 | 68 |
| 3. juli 2024 | 71 |
| 2. juli 2024 | 69 |
| 1. juli 2024 | 66 |
| 30. juni 2024 | 71 |
| 29. juni 2024 | 71 |
| 28. juni 2024 | 75 |
| 27. juni 2024 | 72 |
| 26. juni 2024 | 70 |
| 25. juni 2024 | 71 |
| 24. juni 2024 | 70 |
| 23. juni 2024 | 71 |
| 22. juni 2024 | 71 |
| 21. juni 2024 | 72 |
| 20. juni 2024 | 73 |
| 19. juni 2024 | 71 |
| 18. juni 2024 | 67 |
| 17. juni 2024 | 65 |
| 16. juni 2024 | 71 |
| 15. juni 2024 | 71 |
| 14. juni 2024 | 71 |
| 13. juni 2024 | 68 |
| 12. juni 2024 | 64 |
| 11. juni 2024 | 65 |
| 10. juni 2024 | 63 |
| 9. juni 2024 | 66 |
| 8. juni 2024 | 66 |
| 7. juni 2024 | 63 |
| 6. juni 2024 | 59 |
| 5. juni 2024 | 55 |